GENERAL
Biocon Partner Bags Malaysia Insulin Contracts Worth Over MYR 225 Mn
Biocon Ltd, an innovation-led global biopharmaceutical company, said its long-standing partner, Duopharma Biotech Berhad, through its wholly owned subsidiary Duopharma (M) Sendirian Berhad, has secured multiple insulin supply contracts from Malaysia’s Ministry of Health (MoH) worth more than MYR 225 million. Under the contracts, Biocon’s Malaysian subsidiary, Biocon Sdn. Bhd., will supply short-acting recombinant human […]
CW Bureau
·
Jun 24, 2026
GENERAL
Indian Pharma Firms To Gain Up To $5 Bn From Global Patent Cliff: CareEdge
Indian pharmaceutical companies are poised to benefit from a major global patent expiry cycle, with drugs generating nearly $142 billion in sales in CY25 set to lose exclusivity between 2026 and 2030, according to a report by CareEdge Ratings. The report estimates that the upcoming patent cliff could create a market opportunity of over $30-40 […]
CW Bureau
·
Jun 19, 2026
GENERAL
Glenmark Pharma Launches Generic Vancomycin Injection In US Market
Glenmark Pharmaceuticals has announced the launch of Vancomycin Hydrochloride for Injection USP in the U.S. market, expanding its injectable portfolio amid growing demand for affordable hospital medicines. The company said the product will be available in 500 mg/vial and 1 g/vial strengths through its U.S.-based arm, Glenmark Pharmaceuticals Inc., USA. Targets $37.9 million market opportunity […]
CW Bureau
·
May 18, 2026
